Issue 1/2004
Content (21 Articles)
Enhancements to theAnnals of surgical oncology
Charles M. Balch, Mark S. Roh, Ken Kornfield
In search of better outcome predictors for patients following resection of colorectal metastases
Michael A. Choti
Hormone replacement therapy: A promoter and modulator of breast cancer
David J. Winchester
Application of molecular diagnosis for detection of peritoneal micrometastasis and evaluation of preoperative chemotherapy in advanced gastric carcinoma
Takuji Mori, Yoshiyuki Fujiwara, Yurika Sugita, Takashi Azama, Takaaki Ishii, Kazuhiro Taniguchi, Keiji Yamazaki, Shuji Takiguchi, Takushi Yasuda, Masahiko Yano, Morito Monden
Lymphazurin 1% versus99mTc sulfur colloid for lymphatic mapping in colorectal tumors: A comparative analysis
Sukamal Saha, Adrian G. Dan, Blake Berman, David Wiese, Elie Schochet, Kimberly Barber, Sharan Choudhri, Sunil Kaushal, Balvant Ganatra, Delip Desai, Marigowda Nagaraju, S. Mannam
Composite pelvic exenteration: Is it worthwhile?
Marvin J. Lopez, Pedro Luna-Pérez
Primary vaginal melanoma: A critical analysis of therapy
Thomas J. Miner, Ruby Delgado, Jonathan Zeisler, Klaus Busam, Kaled Alektiar, Richard Barakat, Elizabeth Poynor
Correlation between MUC5AC expression and the prognosis of patients with adenocarcinoma of the uterine cervix
Akira Mitsuhashi, Kouji Yamazawa, Yuuichiro Nagai, Naotake Tanaka, Hideo Matsui, Souei Sekiya
Human telomerase reverse transcriptase (hTERT) and Ki-67 are better predictors of survival than established clinical indicators in patients undergoing curative hepatic resection for colorectal metastases
David L. Smith, Jean-Charles Soria, Luc Morat, Qinghua Yang, Laure Sabatier, Diane D. Liu, Rabih A. Nemr, Asif Rashid, Jean-Nicolas Vauthey
The characteristics of malignant breast tumors in hormone replacement therapy users versus nonusers
Itzhak Pappo, Ioana Meirshon, Tamar Karni, Nava Siegelmann-Danielli, Varda Stahl-Kent, Judith Sandbank, Ilan Wasserman, Ariel Halevy
Breast cancer in patients with residual invasive carcinoma is more accurately staged with additive tumor size assessment
S. T. Hollenbeck, C. Cellini, P. Christos, Y. Varnado-Rhodes, D. Martins, M. Nussbaum, M. P. Osborne, R. M. Simmons
Autofluorescence and diffuse reflectance properties of malignant and benign breast tissues
Tara M. Breslin, Fushen Xu, Gregory M. Palmer, Changfang Zhu, Kennedy W. Gilchrist, Nirmala Ramanujam
Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma
Stephen D. W. Beck, Manish I. Patel, Mark E. Snyder, Michael W. Kattan, Robert J. Motzer, Victor E. Reuter, Paul Russo
Atypical lipomatous tumor/well-differentiated liposarcoma of the extremity and trunk wall: Importance of histological subtype with treatment recommendations
David A. Kooby, Cristina R. Antonescu, Murray F. Brennan, Samuel Singer
Melanoma-inhibiting activity assay predicts survival in patients receiving a therapeutic cancer vaccine after complete resection of american joint committee on cancer stage III melanoma
Mark B. Faries, Rishab K. Gupta, Xing Ye, Eddy C. Hsueh, Donald L. Morton
The utility of frozen section evaluation for follicular thyroid lesions
Rachael A. Callcut, Suzanne M. Selvaggi, Eberhard Mack, Omer Ozgul, Thomas Warner, Herbert Chen
A new in vitro assay for human tumor angiogenesis: Three-dimensional human tumor angiogenesis assay
Seza A. Gulec, Eugene A. Woltering